Lilly gets FDA okay for tirzepatide as obesity therapy November 8, 2023 AutoBot News 0 Novo Nordisk is finally facing some major competition to its obesity franchise juggernaut, now that Eli Lilly’s rival therapy tirzepatide has been approved by the FDA as a weight-loss drug.